NCT06908564

Brief Summary

The effects of new technologies, particularly exergames, on the rehabilitation process of patients with hip arthroplasty have not yet been verified. For this reason, the aim of this study is to evaluate the effectiveness, in terms of balance recovery, of a balance rehabilitation program based on serious games in individuals with hip arthroplasty compared to conventional treatment.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2023

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 23, 2023

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

March 27, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 3, 2025

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 23, 2026

Completed
Last Updated

April 9, 2025

Status Verified

April 1, 2025

Enrollment Period

2.5 years

First QC Date

March 27, 2025

Last Update Submit

April 7, 2025

Conditions

Keywords

Hip Arthroplasty ReplacementLower LimbBalanceRehabilitationRobotic-Assisted TherapyRange Of MotionPainActivity of Daily LivingHip Replacement Total

Outcome Measures

Primary Outcomes (1)

  • Time Up and Go Test (TUG)

    Time up and go test assess fall risk and measure the progress of balance, sit to stand and walking. Simple screening test that is a sensitive and specific measure of probability for falls among older adults. This test is intended to population affected by Parkinson's Disease, Multiple Sclerosis, Alzheimer's, Hip fracture, Total Knee Arthroplasty, Total Hip Replacement, Stroke and Huntington Disease. Materials needed consist in one chair with armrest, stopwatch and tape for mark 3 meters. Patients wear their regular footwear and can use a walking aid, if needed. The patient starts in a seated position and stands up upon therapist's command: walks 3 meters, turns around, walks back to the chair and sits down. The time stops when the patient is seated. Be sure to document the assistive device used. The score is calculated in seconds and high scores indicate an elevate risk of falling.

    Day 0 (T0 - baseline), day 30 (T1 - After treatment).

Secondary Outcomes (8)

  • Cognitive Time Up and Go Test (TUG-C)

    Day 0 (T0 - baseline), day 30 (T1 - After treatment).

  • Passive Range of Motion (p-ROM)

    Day 0 (T0 - baseline), day 30 (T1 - After treatment).

  • Ten Meter Walking Test (10MWT)

    Day 0 (T0 - baseline), day 30 (T1 - After treatment).

  • Hip Dysfunction and Osteoarthritis Outcome Score for Joint Replacement (HOOS JR).

    Day 0 (T0 - baseline), day 30 (T1 - After treatment).

  • Medical Research Council Scale (MRC)

    Day 0 (T0 - baseline), day 30 (T1 - After treatment).

  • +3 more secondary outcomes

Other Outcomes (4)

  • Bilateral thigh cytometry.

    Day 0 (T0 - baseline), day 30 (T1 - After treatment).

  • Number of falls in the last 3 months.

    Day 0 (T0 - baseline), day 30 (T1 - After treatment) and day 120 (T2 - 3 months after treatment).

  • Client satisfaction questionnaire .

    Day 30 (T1 - After treatment).

  • +1 more other outcomes

Study Arms (2)

Experimental Group (EG)

EXPERIMENTAL

The Experimental Group (EG) perform 30 minutes (16 sessions, 4 days/week, for 4 weeks) of balance rehabilitation exercises using non-immersive virtual reality with the OAK device (Khymeia Group, Italy).

Device: Experimental: Interactive balance rehabilitation based on serious games.

Active comparator (CG)

ACTIVE COMPARATOR

Partecipants assigned to Control Group (CG) follow 30 minutes (4 days/week, for 4 weeks) of conventional rehabilitative treatments for balance without the use of technological devices.

Other: Active Comparator: conventional balance rehabilitation without the use of technological devices.

Interventions

The intervention of the Experimental Group consists of 30 minutes (16 sessions, 4 days/week, for 4 weeks) of balance rehabilitation exercises using non-immersive virtual reality through the OAK device (Khymeia Group, Italy). The system includes exercises that require the patient to reach visual targets by shifting their Center of Pressure (COP). The exercises are categorized based on the direction of COP displacement and can be performed with increasing difficulty, as determined by the physiotherapist during the rehabilitation process.

Experimental Group (EG)

Intervention of the Control Group (CG) consists of 30 minutes (4 days/week, for 4 weeks) of conventional balance rehabilitation treatments without the use of technological devices. The motor exercises will focus on the rehabilitation of balance, the trunk, and the lower limbs and will be carried out with a physiotherapist who will tailor the treatment according to the patient's characteristics and needs. Primary attention will be given to recovering trunk control and seated posture. This phase will focus on restoring and maintaining muscle trophism in the anterior and posterior kinetic chains of the thigh and lower leg, as well as the hip's range of motion, through isometric exercises and gentle joint mobilizations while adhering to anti-dislocation guidelines. The process will continue with the reacquisition of the upright stance, emphasizing proprioceptive, coordination, and balance abilities. Once the upright position is stabilized, gait re-education will be introduced.

Active comparator (CG)

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age over 18 years;
  • First elective hip arthroplasty;
  • Cognitive ability to understand and perform the exercises outlined in the protocol;
  • Ability to sign the informed consent.

You may not qualify if:

  • Unable to adhere to the exercise program due to poor compliance;
  • Previous contralateral hip arthroplasty;
  • Surgical wound complications;
  • Severe cognitive, linguistic, or visual impairments (inability to understand and follow the study procedures);
  • Conditions that, in the investigator's judgment, may interfere with the study or contraindicate participation for safety reasons;
  • Diagnosis of epilepsy;
  • Presence of implanted cardiac pacemakers;
  • Lack of signed informed consent for the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

IRCCS San Raffaele Roma

Rome, Italy, 00163, Italy

RECRUITING

Casa di Cura San Raffaele Sulmona

Sulmona, Italy, 67039, Italy

RECRUITING

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Prof. Marco Franceschini, MD

    IRCCS San Raffaele Roma

    STUDY CHAIR
  • Prof. Marco Franceschini, MD

    IRCCS San Raffaele Roma

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Dr. Sanaz Pournajaf, DPT

CONTACT

Dr. Carlotta Maria Manzia, DT

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Masking Details
This study is assessor-blinded, meaning that the outcome assessors will be masked to group allocation to minimize bias in data collection and analysis. Other study personnel, including participants and intervention providers, will not be blinded.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 27, 2025

First Posted

April 3, 2025

Study Start

June 23, 2023

Primary Completion

December 31, 2025

Study Completion

March 23, 2026

Last Updated

April 9, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will share

De-identified individual participant data (IPD) related to primary and secondary outcome measures will be shared, including assessment results and relevant demographic data, in compliance with ethical and legal requirements.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
IPD and supporting information will be available after official publication and upon request.
Access Criteria
Access will be granted upon specific request to the Study Chair, Principal Investigator, Sub-Investigator, or Central Study Contact Person. Researchers must submit a formal proposal outlining the intended use of the data, which will be reviewed for scientific merit and ethical compliance. Approved requests will receive access through a secure data-sharing platform.

Locations